Efficacy of rabeprazole for the treatment of gastroesophageal reflux disease in a 7-day non-interventional trial
As a result of 7-day therapy of patients with NERD and esophagitis with Razo<sup>®</sup> at a dose of 20 mg per day, an excellent clinical response was obtained, confirmed by a marked optimization of pH-impedancemetry parameters.
Authors
- Е. В. Онучина (ORCID: https://orcid.org/0000-0003-1954-6639)
- В. В. Цуканов (ORCID: https://orcid.org/0000-0002-9980-2294)
- A. V. Vasyutin (ORCID: https://orcid.org/0000-0002-6481-3196)
- Yu.L. Tonkikh (ORCID: https://orcid.org/0000-0001-7518-1895)
- Н. В. Павлова (ORCID: https://orcid.org/0000-0002-8909-8707)
- Bairma B. Dambaeva
Institutions
- Dr. Reddy's Laboratories (United States) (US)
- Krasnoyarsk Scientific Center (RU)
- Russian Medical Academy of Continuous Professional Education (RU)
Publication Details
- Journal
- Terapevticheskii arkhiv
- Published
- 2024-09-14
- DOI
- https://doi.org/10.26442/00403660.2024.08.202895
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00